In the most recent quarter, institutional shares of BioXcel Therapeutics, Inc. (BTAI) experienced a significant increase of 829.33%. This surge in institutional ownership indicates a notable accumulation of shares by funds during that period.1
As of the most recent data, BTAI has 38 institutional owners and shareholders who have filed 13D/G or 13F forms with the SEC, collectively holding a total of 384,437 shares.1 The total institutional value of these long positions stands at $745,000 USD.1
While the Fintel data confirms the substantial increase in institutional holdings, the specific factors driving this accumulation often stem from a combination of market conditions and company-specific developments. One potential contributing factor is the stock's price performance leading up to this period. The share price of BTAI saw a significant decline of 77.30% from August 7, 2024, ($14.58 per share) to August 6, 2025, ($3.31 per share).1 Such a substantial price drop can attract institutional investors looking for value or potential turnaround opportunities.
Additionally, analyst sentiment may have played a role. In March 2025, Rodman & Renshaw initiated coverage of BioXcel Therapeutics with a "Buy" recommendation, which could have signaled renewed interest to institutional investors.2 However, analyst price targets for BTAI showed considerable volatility in early to mid-2025, with a significant increase in February 2025 followed by subsequent decreases in March and June 2025.2
Among the largest institutional shareholders identified are Murchinson Ltd., UBS Group AG, Goldman Sachs Group Inc, BlackRock, Inc., Geode Capital Management, Llc, Beacon Pointe Advisors, LLC, Vanguard Group Inc, VEXMX - Vanguard Extended Market Index Fund Investor Shares, FSMAX - Fidelity Extended Market Index Fund, and Wells Fargo & Company/mn.1 The Fintel "Fund Sentiment Score" (formerly Ownership Accumulation Score) is designed to identify companies with high levels of institutional accumulation, suggesting that BTAI was actively being bought by funds.1
For more detailed information on BTAI's institutional ownership, including a breakdown of individual fund holdings and historical filing data, you can visit the Fintel BTAI institutional ownership page.
